Task: Answer the multiple choice question.
Query: Which drug exhibits a 4.651% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCNC(=S)NCc1ccc2c(c1)OCO2
b) CCCCCC(O)(CCN1CCCCC1)c1ccc(OCC)cc1.Cl
c) Cc1cccc(NC(=O)CSc2nc3nc(C)cc(C)c3c(=O)[nH]2)c1
Answer: c. Cc1cccc(NC(=O)CSc2nc3nc(C)cc(C)c3c(=O)[nH]2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(NC(=O)CSc2nc3nc(C)cc(C)c3c(=O)[nH]2)c1
Cc1cccc(NC(=O)CSc2nc3nc(C)cc(C)c3c(=O)[nH]2)c1
2-[(5,7-dimethyl-4-oxo-3H-pyrido[2,3-d]pyrimidin-2-yl)sulfanyl]-N-(3-methylphenyl)acetamide